BRIEF-Dynavax presents encouraging data from clinical trial of immuno-oncology product candidate, SD-101

* Dynavax presents encouraging data from clinical trial of immuno-oncology product candidate, SD-101 Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.